Vivoryon Therapeutics

About:

Vivoryon is a clinical stage company focused on bringing first-in-class therapies to patients suffering from age-related diseases.

Website: https://www.vivoryon.com

Twitter/X: vivoryonnv

Top Investors: Andera Partners, Biogen, EQT Life Sciences, bmp Ventures, IBG Beteiligungsgesellschaft Sachsen-Anhalt

Description:

Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.

Total Funding Amount:

$189M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Halle An Der Saale, Sachsen-Anhalt, Germany

Founded Date:

1997-01-01

Founders:

Konrad Glund

Number of Employees:

101-250

Last Funding Date:

2022-09-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai